Though UDR's Q1 results will likely mirror benefits from favorable demographics, household formation, decent economy and job-market gains, high deliveries of new units remains a drag.
Booz Allen's (BAH) fourth-quarter fiscal 2019 results should reflect strong contract level performance, operational excellence and cost management.
Weather conditions, higher tax rate negatively impact Rollin's first-quarter 2019 results.
Amphenol's (APH) first-quarter 2019 results benefit from strong growth across company's end markets.
With oil popping up to $60.55 a barrel, the March quarter witnesses the fastest rate of oil price hike since 2009.
Amarin's (AMRN) cardiovascular drug, Vascepa to drive sales in the first quarter.
Snap (SNAP) first-quarter 2019 results benefit from growth in DAUs and user engagement levels owing to the company's innovation strategies.
Though most of the stocks in the ETFs portfolio have delivered impressive returns, a few were the real stars gaining more than 50%.
Nasdaq (NDAQ) records lower expenses in Q1, offset by decrease in revenues.
During Trevena's (TRVN) first-quarter 2019 conference call, investor focus will be on the company's progress to support its development of the pain therapy ??? oliceridine injection.
Biogen (BIIB) beats estimates for both earnings and sales in the first quarter fueled mainly by strong performance of its muscle disease drug, Spinraza in international markets.
Boston Scientific (BSX) is investing in new technologies and the global markets, which in turn, aids the uptick in sales across its most geographies in Q1.
Boeing's (BA) revenues surpass the Zacks Consensus Estimate but decline on a year-over- year basis.
We expect passenger revenues to grow for airline companies that are scheduled to release first-quarter 2019 numbers in the coming days.
Thermo Fisher (TMO) reports strong Laboratory Products and Services performance, flaunting robust global demand.
Amazon.com (AMZN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Higher revenues boost Norfolk Southern's (NSC) first-quarter 2019 results. Improvement in operating ratio is an added positive.
Intel (INTC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
AbbVie (ABBV) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
MGIC Investment (MTG) Q1 results reflect increased Insurance in force, solid persistency, lower delinquency and low credit losses.